Recall Register

Food, drugs, devices › AGFA Corp.

Device recall: IMPAX RIS QDOC 5.8

FDA enforcement event 67275 · Class II · initiated 8 Jan 2014 · status Terminated · terminated 28 Feb 2014

DeviceVoluntary: Firm initiated1 product recordGreenville, SC

AGFA Corp. (Greenville, SC) initiated this device recall on 8 Jan 2014; FDA lists 1 product record under event 67275, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,176 device enforcement events initiated in 2014 carry the same class.

Status: Terminated, terminated 28 Feb 2014. Initiation: voluntary: firm initiated. AGFA Corp. has 11 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

AGFA Corp., Greenville, SC.

Reason for recall

"Patient name displayed (printed) on the Patient Report was the wrong patient name."

Distribution

"CA, FL, GA, ME, OH, OR, SC, SD, TX and Canada"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0919-2014IMPAX RIS QDOC 5.814Class IITerminated12 Feb 2014

Context

91%of 2014 device events are Class II1,176 events that year
1product record in this eventfirm median: 1
11events on this register for the firm

Other enforcement events for AGFA Corp.

InitiatedProduct (first record)TypeClassRecords
6 Jun 2014AGFA Digital Radiography X-Ray system DX-D 100 Agfa's DX-D 100 is indicated for use in providing diagnostic quality imagDeviceClass II1
30 Apr 2014IMPAX CV Pediatric Echo Reporting, IMPAX CV Echo Measurement Import via Optical Character Recognition (OCR) Service IMPADeviceClass II1
19 Sep 2013IMPAX 5.2 DB Server (running Oracle 10.1.0.4.0), medical imaging Picture Archiving and Communication System (PACS).DeviceClass II1
15 May 2013AGFA Digital Radiography X-Ray System DX-D 100 Agfa's DX-D 100 is indicated for use in providing diagnostic quality imagDeviceClass II1
15 Mar 2013IMPAX CV Reporting Cardiac Catheterization module and IMPAX CV Outbound Reporting. Facilitates digital reports for catheDeviceClass II1
15 Mar 2013IMPAX CV 7.8 SU3 - OCR Service. The IMPAX CV Reporting component facilitates the quick , effective creation of digital sDeviceClass II1
7 Feb 2013CR MD1.0 General Set, x-ray imager image plate. CR 10-X Image Plate 35CM X 43CM. An image plate, contained in an X-Ray cDeviceClass II1
9 Aug 2012AGFA IMPAC CV DICOMStore with Media Purge Daemon (MPD) and IMPAX CV DICOMStore with Cardiovascular Purge Services (CPS),DeviceClass II1
27 Jul 2012IMPAX Cardiovascular (CV) Reporting Reporting tool used for structured reporting and structured report outputs (includinDeviceClass II1
10 Jul 2012IMPAX CV Reporting The Results Management (RM)/IMPAX CV reporting component facilitates the quick, effective creating ofDeviceClass II1

All 11 events for AGFA Corp.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Patient name displayed (printed) on the Patient Report was the wrong patient name."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "CA, FL, GA, ME, OH, OR, SC, SD, TX and Canada"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 28 Feb 2014. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.